165 related articles for article (PubMed ID: 20849407)
21. Prevalence of leucocyte antibodies in non-transfused male and female platelet apheresis donors.
Simtong P; Sudwilai Y; Cheunta S; Leelayuwat C; Romphruk AV
Transfus Med; 2021 Jun; 31(3):186-192. PubMed ID: 33949000
[TBL] [Abstract][Full Text] [Related]
22. The prevalence of leucocyte alloantibodies in blood donors from South China.
Xia W; Ye X; Xu X; Chen D; Deng J; Chen Y; Ding H; Shao Y; Wang J; Liu J; Li H; Huang YF; Fu Y; Santoso S
Transfus Med; 2015 Dec; 25(6):385-92. PubMed ID: 26876912
[TBL] [Abstract][Full Text] [Related]
23. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
24. Anti-human leukocyte antigen antibodies are present in blood of blood donors: is therapy with blood preparations safe for graft recipients?
Nowosiad-Magda M; Myślak M; Roszkowska P; Borowiec-Chłopek Z; Krasnodębska-Szponder B; Kłosińska E; Agapow A; Giedrys-Kalemba S
Transplant Proc; 2014 Oct; 46(8):2565-71. PubMed ID: 25380867
[TBL] [Abstract][Full Text] [Related]
25. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
Kleinman S; Grossman B; Kopko P
Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
[TBL] [Abstract][Full Text] [Related]
26. Results of HLA antibody testing using ELISA vs the fluorescent bead method and retrospective review of data for recipients of packed RBCs and platelets from male HLA-immunized donors.
Aung FM; Cano P; Fernandez-Vina M; Lichtiger B
Am J Clin Pathol; 2011 Jan; 135(1):90-5. PubMed ID: 21173129
[TBL] [Abstract][Full Text] [Related]
27. An association between ABO group and HLA antibody detection.
Dunbar NM; Yazer MH; Bravo MD; Kamel HT; Gorlin J; Norris PJ; Williamson PC; Vassallo RR;
Transfusion; 2017 Feb; 57(2):313-318. PubMed ID: 27807878
[TBL] [Abstract][Full Text] [Related]
28. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
29. Two cases of transfusion-related acute lung injury triggered by HLA and anti-HLA antibody reaction.
Lee JH; Kang ES; Kim DW
J Korean Med Sci; 2010 Sep; 25(9):1398-403. PubMed ID: 20808691
[TBL] [Abstract][Full Text] [Related]
30. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
[TBL] [Abstract][Full Text] [Related]
31. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
Keller-Stanislawski B; Reil A; Günay S; Funk MB
Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
[TBL] [Abstract][Full Text] [Related]
32. Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff.
Carrick DM; Johnson B; Kleinman SH; Vorhaben R; Chance SC; Lee JH; Roback JD; Pandey S; Sun Y; Busch MP; Norris PJ;
Transfusion; 2011 May; 51(5):1105-16. PubMed ID: 21087285
[TBL] [Abstract][Full Text] [Related]
33. Are we underestimating reverse TRALI?
De Clippel D; Emonds MP; Compernolle V
Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
[TBL] [Abstract][Full Text] [Related]
35. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of HLA sensitization in female apheresis donors.
Densmore TL; Goodnough LT; Ali S; Dynis M; Chaplin H
Transfusion; 1999 Jan; 39(1):103-6. PubMed ID: 9920173
[TBL] [Abstract][Full Text] [Related]
37. A specific assay for anti-HLA antibodies: application to platelet donor selection.
Millard FE; Tani P; McMillan R
Blood; 1987 Nov; 70(5):1495-9. PubMed ID: 3311206
[TBL] [Abstract][Full Text] [Related]
38. [HLA and transfusion: new approaches with Luminex™ technology].
Giannoli C; Nguyen TK; Dubois V
Transfus Clin Biol; 2011 Apr; 18(2):218-23. PubMed ID: 21397543
[TBL] [Abstract][Full Text] [Related]
39. The frequency and specificity of human neutrophil antigen antibodies in a blood donor population.
Gottschall JL; Triulzi DJ; Curtis B; Kakaiya RM; Busch MP; Norris PJ; Glynn SA; Carrick D; Wright DJ; Kleinman S;
Transfusion; 2011 Apr; 51(4):820-7. PubMed ID: 20977484
[TBL] [Abstract][Full Text] [Related]
40. The mystery of transfusion-related acute lung injury.
Blumberg N; Sime PJ; Phipps RP
Transfusion; 2011 Oct; 51(10):2054-7. PubMed ID: 21985040
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
